1. Home
  2. RSKD vs KROS Comparison

RSKD vs KROS Comparison

Compare RSKD & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riskified Ltd.

RSKD

Riskified Ltd.

HOLD

Current Price

$3.96

Market Cap

661.3M

Sector

Technology

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.69

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSKD
KROS
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.3M
584.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RSKD
KROS
Price
$3.96
$11.69
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$5.96
$22.25
AVG Volume (30 Days)
820.7K
457.8K
Earning Date
03-04-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.00
EPS
N/A
2.30
Revenue
N/A
$243,864,000.00
Revenue This Year
$12.10
N/A
Revenue Next Year
$10.19
$727.07
P/E Ratio
N/A
$4.80
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$9.12
52 Week High
$5.68
$22.55

Technical Indicators

Market Signals
Indicator
RSKD
KROS
Relative Strength Index (RSI) 39.82 45.14
Support Level N/A $10.49
Resistance Level $4.91 $15.97
Average True Range (ATR) 0.14 0.55
MACD -0.02 0.26
Stochastic Oscillator 37.86 92.88

Price Performance

Historical Comparison
RSKD
KROS

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: